GLP-1 Drug Microdosing Becomes Off-Label Medical Experiment

Livemint · health

GLP-1 receptor-agonist weight-loss drugs have gained immense popularity, leading to an off-label medical experiment known as "microdosing." This involves taking less than the recommended dosage, with one estimate suggesting one in seven users have tried it. An industry has emerged in America offering microdosing through online firms like Noom and Hims & Hers, medical spas, and even self-administration at home. This widespread practice raises significant concerns about its safety and efficacy.